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Keratinocyte Growth Factor (KGF/FGF7) is a candidate andromedin in normal embryonic development of
male accessory sex glands, such as the prostate and seminal vesicles. The expression of KGF mRNA and protein
is androgen-responsive. To elucidate the regulation of expression of the KGF gene, we isolated the first two
exons of the KGF gene and approximately 15 kb upstream sequences. The major transcription start site was
mapped. It is preceded by a CAAT-box and a TATA-box. Transient transfections in LNCaP cells revealed that,
upon treatment with the synthetic androgen R1881, KGF promoter activity is upregulated 6 to 11 fold, indicating
androgen regulation of the KGF promoter in the region from position −1900 to −1200. The longest construct
(BH-pLuc: −4700 to +901) has a much higher basal activity than the shorter constructs, indicating that in the
region −4700 to −2700 additional activating sequences are present. © 1996 Academic Press, Inc.
Keratinocyte Growth Factor (KGF or FGF7) is a member of the Fibroblast Growth Factor
family. KGF is exclusively expressed in mesenchymal and stromal cells of many organs and has
a specific mitogenic effect on epithelial cells (1, 2), which express the KGF-receptor, a splice
variant of Fibroblast Growth Factor Receptor 2 (3). The expression patterns of KGF and its
high-affinity receptor have led to the assumption that KGF is a mediator of mesenchymal-epithelial
cellular interactions (4, 5).
During development of male accessory sex glands, androgen-driven interactions between the
mesenchyme and the epithelium are essential (6). The mesenchyme is the target of androgens,
which is consistent with the finding that functional androgen receptors, which mediate the actions
of androgens, prenatally and perinatally can only be detected in mesenchymal cells of the prostate
(7). The intracellular androgen receptor is a ligand-dependent transcription factor and a member of
the steroid/thyroid hormone/retinoic acid receptor family (8,9). Defects in androgen receptor pro-
duction or function result in aberrant male sexual development (10). Since in prostate (11) and
seminal vesicles (12) KGF is expressed in mesenchymal cells, and the expression of the KGF
mRNA as well as of the protein is androgen-responsive (11), KGF is considered to be an important
candidate andromedin in normal development of male accessory sex organs. The possible role of
KGF in androgen-driven development has recently been investigated in in vitro organ culture
experiments. Administration of a KGF-antibody to the growth medium of in vitro grown newborn
mouse seminal vesicles (12) and rat ventral prostates (13), results in inhibited growth of these
organs and in inhibition of the epithelial branching morphogenesis. When newborn seminal
vesicles were grown in Testosterone (T)-depleted medium and subsequently KGF was added,
growth was approx. 50% compared to newborn seminal vesicles that were grown in medium + T.
In this study we describe the initial characterization of the rat KGF promoter and its activation
by androgens.
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MATERIALS AND METHODS
Screening of a rat genomic library. A rat genomic EMBL3 l-phage library (courtesy of A.P.N. Themmen, Rotterdam)
was screened with a [32P]-dATP (Amersham Ltd., Amersham, United Kingdom (UK)) random-labeled KGF specific 59
cDNA PCR probe obtained by amplification on rat genomic DNA (primer A: 59-CACAGATAGGAGGAGGCCCAT-39;
primer B: 59-GCTAGAACAGTTCACGCTCGT-39(14)) under standard conditions (15). Positive plaques were picked,
purified and DNA was isolated. DNA of each clone was subsequently digested with a panel of restriction enzymes and
subjected to Southern blot analysis to generate a restriction map. Appropriate fragments were subcloned and sequenced.
Cell culture. LNCaP cells were cultured in RPMI 1640, supplemented with 5% fetal calf serum (Boehringer Mannheim,
Germany) and antibiotics. For transfection experiments, cells were grown in Dulbecco’s Modification of Eagle’s Medium
supplemented with 5% steroid-depleted (dextran-charcoal treated) fetal calf serum. For examination of androgen-driven
promoter activation, the synthetic androgen R1881 (New England Nuclear, Boston, MA) was added to a final concentration
of 1 nM.
Constructs for transient transfections. The human androgen receptor expression plasmid pARO was described previously
(16). The promoterless plasmid pLuc, which was used for cloning of KGF promoter fragments in front of the Luc reporter
gene, was derived from pSLA3 (17) by insertion of an oligonucleotide containing a multiple cloning site (MCS) in the
HindIII and NcoI sites of pSLA3 (18). KGF-pLuc reporter plasmids were generated by ligation of appropriate fragments
in the MCS of pLuc. Constructs contain the following KGF promoter fragments: BamHI/HpaI-pLuc (BH-pLuc): −4700 to
+901; EcoRV/EcoRV/HpaI-pLuc (EEH-pLuc): −2700 to +901; EcoRV/HpaI-pLuc (EH-pLuc): −1900 to +901; SacI/HpaI-
pLuc (SH-pLuc): −1200 to +901; PvuII/HpaI-pLuc (PH-pLuc): −536 to +901; HindIII/HpaI-pLuc (HH-pLuc): −66 to +901.
Transient transfections. Transient transfections of LNCaP cells were performed according to the calcium phosphate
precipitation method essentially as described (19), using 1 × 106 cells per 25 cm2 flask, 5 mg of the appropriate KGF-pLuc
construct and 2.5 mg pARO. Supercoiled plasmid DNA for transfections were isolated over Qiagen Plasmid-tips (Qiagen,
Hilden, Germany). After 4 hr incubation with the precipitate, culture medium was removed and replaced by phosphate
buffered saline (PBS), containing 15% glycerol for a 90 sec incubation at room temperature. Subsequently, transfected cells
were incubated in culture medium with or without R1881 for at least 24 hr. Transfections were performed at least four times,
with two different isolates of the appropriate plasmids.
Luciferase assay. Cells were washed once with PBS and lysed in 300 ml lysis buffer (25 mM Tris-phosphate pH 7.8, 8
mM MgCl2, 1mM DTT, 1% Triton X-100, 15% glycerol). Subsequently, 100 ml Luciferin (0.25 mM) (Sigma, St. Louis,
MO)/0.25 mM ATP was added to 100 ml of each extract, and luciferase activity was measured in a LUMAC 2500 M
Biocounter (LUMAC, Landgraaf, The Netherlands).
Rapid Amplification of cDNA ends (RACE). The RACE protocol was performed on 59-RACE-Ready cDNA (Clontech,
Palo Alto, CA) according to the directions of the manufacturer. In brief, PCR (45 sec 94°C, 60 sec 60°C, 2 min 72°C for
30 cycles, followed by a 7 min extension at 72°C) was performed on 59 anchored cDNA using the supplied anchor primer
and the KGF specific primer RACE 1: 59-TACTCCTAGGTCATGGGCCTC-39. PCR products were separated on a 2%
agarose gel and blotted to a Hybond N+ filter (Amersham Ltd., Amersham, UK) for Southern blot analysis. Filters were
hybridized with a [32P]-dATP random-labeled 504 bp HindIII-BamHI KGF promoter fragment, followed by washes to 1 ×
SSC/0.1% SDS at 65°C. Filters were exposed for autoradiography at −80°C.
RESULTS
Isolation of the Rat KGF Promoter
To isolate the promoter of the rat KGF gene, we screened a rat genomic library with a 240 bp
KGF cDNA probe (see Materials and Methods). One of the phage inserts isolated (11.2) contained
the 59 part of the KGF gene and approximately 15 kb upstream sequences. Figure 1a shows a
restriction map of a region of clone 11.2 that spans approx. 6 kb. By comparing the genomic
sequences obtained from clone 11.2 to cDNA sequences, we found that, besides the three exons
known so far of the KGF gene (20), an additional upstream exon is present (exon 1A). The size of
intron 1A is 585 bp. In the lower part of figure 1a the 59 region of the KGF gene with a part of exon
1B, intron 1A and exon 1A is presented in more detail. Figure 1b shows the sequences obtained
from the 59 region of the KGF gene. The exon/intron boundaries are according to consensus
sequences.
To determine the exact 59 boundary of exon 1A and to map the transcription start site we
performed Rapid Amplification of cDNA Ends (RACE) on 59-RACE-ready rat kidney cDNA.
Southern blot analysis of the product is depicted in Figure 1c. One specifically hybridizing band
of approx. 400 bp was detected. The fragment was cloned and the major transcription start site was
mapped by sequencing (see Figure 1b). This start site is preceded by a CAAT box at position −51
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FIG. 1. Characterization of the rat KGF promoter. (a) Partial restriction map of the KGF promoter region. B, BamHI;
EV, EcoRV; S, SacI, P, PvuII, HIII, HindIII, Hp, HpaI. In the lower part the organization of the 59 part of the KGF gene
is shown in more detail. Boxes represent exons. Untranslated cDNA is represented by an open box, translated sequences
by a hatched box. The major transcription start site is indicated by the arrow. (b) Sequence of the 59 part of the KGF gene.
Translated sequences are in bold letters. The transcription start site, CAAT and TATA box are in lower case letters and
double underlined. Intron sequences are in lower case letters. The position of primer RACE 1 is underlined. (c) Southern
blot analysis of KGF RACE cDNA. For experimental details see Materials and Methods.
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and a TATA box at position −32 (Figure 1b). Some transcripts start at the A or the T at positions
−103 and −102 respectively, but they represent a far minority of all cDNA fragments examined.
The Rat KGF Promoter Is Androgen Responsive in Transient Transfections
Deletion constructs of the KGF promoter hooked to the Luc reporter gene were transiently
transfected LNCaP cells together with the androgen receptor expression plasmid pARO. We used
a series of deletion constructs containing upstream sequences (see Materials and Methods). Figure
2 shows the results of the experiments. All KGF deletion constructs showed basal promoter activity
compared to the “empty” luciferase reporter plasmid as a control, but the longest construct (BH-
pLuc: −4700/+901) had a 5 to 15 fold higher basal activity than the shorter constructs. When cells
were incubated in the presence of the synthetic androgen R1881, constructs HH-pLuc, PH-pLuc,
and SH-pLuc did not show a marked induced Luc activity upon R1881 treatment. However a 6 to
11 fold induction of Luc activity was measured upon treatment with 1 nM R1881 in the 3 longer
constructs (BH-pLuc, EEH-pLuc and EH-pLuc). Although the androgen induction of BH-pLuc was
lower than of the shorter constructs (6-fold compared to 11-fold), again, the absolute promoter
activity was highest of all constructs. The drop in R1881 inducibility between EH-pLuc and
SH-pLuc suggests that the region between positions −1900 and −1200 is involved in androgen
regulation of the KGF promoter.
FIG. 1.—Continued.
FIG. 2. Transient transfections of LNCaP cells with deletion constructs of the KGF promoter region and the human
androgen receptor expression vector (pARO). KGF promoter fragments were cloned in front of the Luciferase reporter gene.
Cells were grown in the absence (open bar) and presence of 1 nM R1881 (black bar). Relative induction factors are indicated
at the top of the bars.
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DISCUSSION
KGF is considered to be a candidate andromedin in the development of male accessory sex
glands (21). Our observations support this concept as we show that KGF promoter activity is
regulated by androgens. In transient transfections, the region from position −1900 to −1200 is
involved in this androgen regulation of the KGF promoter, which was confirmed when we cloned
the genomic fragment in front of a minimal TK-promoter in a Luc reporter vector. Also in this
setting Luc activity was upregulated after treatment with R1881 (data not shown). It can be
presumed that the −1900 to −1200 fragment contains one or more androgen receptor binding sites.
Further sequence analysis, combined with functional studies and in vitro protein-DNA interactions,
may reveal the details of androgen regulation of the KGF promoter.
From the results of the transient transfections, presented in figure 2, it is clear that, although all
KGF deletion constructs show basal activity, BH-pLuc (−4700 to +901) is by far most active. Upon
treatment with androgens, the induction of BH-pLuc is lower than that of the shorter constructs,
but, again, the absolute promoter activity is much higher. This may mean, that in the −4700 to
−2700 region additional activating sequences are present, as well as sequences, that modulate the
androgen-induction.
Recently the human KGF promoter was isolated (22). Comparison of the sequences of the rat
KGF promoter to the human promoter shows that the homology is high up to position −255 in the
rat promoter (78%), upstream of this point sequences diverge (data not shown). The human KGF
promoter contains two transcription start sites, whereas in the rat KGF promoter we found one
major transcription start site. The location of the major start site is identical in both genes. Both the
human and the rat KGF promoter have a CAAT-box and a TATA-box upstream of the major
transcription start site.
In this study we used LNCaP epithelial prostatic carcinoma cells for our transfection experi-
ments, since LNCaP cells endogenously express the androgen receptor and can easily be trans-
fected (18). Available rat mesenchymal (rUGM (23)) and stromal (Nbf-1 (24)) prostatic cell lines
were not transfectable. The human KGF promoter could not be activated in a number of transfected
epithelial cell lines tested, which were further shown not to express KGF mRNA (21). We have
investigated endogenous KGF mRNA expression in LNCaP cells on a Northern blot and we could
detect the 2.4 kb KGF transcript (data not shown).
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